131 related articles for article (PubMed ID: 36319019)
1. Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors.
Konsta M; Nurmohamed MT; Iliopoulos A; Sfikakis PP; van Denderen JC; Visman I; Sakelariou GT; van der Horst-Bruinsma IE
J Rheumatol; 2023 Mar; 50(3):342-350. PubMed ID: 36319019
[TBL] [Abstract][Full Text] [Related]
2. Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis.
Ajrawat P; Touma Z; Sari I; Taheri C; Diaz Martinez JP; Haroon N
Int J Rheum Dis; 2020 Jun; 23(6):728-743. PubMed ID: 32419337
[TBL] [Abstract][Full Text] [Related]
3. Associated Factors with the Severity of Hip Involvement in Spondyloarthritis and Efficacy of TNF α Inhibitors in these Patients.
Slouma M; Rahmouni S; Dhahri R; Cheour E; Gharsallah I; Metoui L; Louzir B
Curr Rheumatol Rev; 2022; 18(1):58-63. PubMed ID: 34636315
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
Beek KJ; Rusman T; van der Weijden MAC; Lems WF; van Denderen JC; Konsta M; Visman I; Nurmohamed MT; van der Horst-Bruinsma IE
J Bone Miner Res; 2019 Jun; 34(6):1041-1048. PubMed ID: 30690799
[TBL] [Abstract][Full Text] [Related]
5. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Molnar C; Scherer A; Baraliakos X; de Hooge M; Micheroli R; Exer P; Kissling RO; Tamborrini G; Wildi LM; Nissen MJ; Zufferey P; Bernhard J; Weber U; Landewé RBM; van der Heijde D; Ciurea A;
Ann Rheum Dis; 2018 Jan; 77(1):63-69. PubMed ID: 28939631
[TBL] [Abstract][Full Text] [Related]
6. Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis.
Konsta M; Sfikakis PP; Bournia VK; Karras D; Iliopoulos A
Clin Rheumatol; 2013 Aug; 32(8):1229-32. PubMed ID: 23604596
[TBL] [Abstract][Full Text] [Related]
7. Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score.
Salaffi F; Carotti M; Garofalo G; Giuseppetti GM; Grassi W
Clin Exp Rheumatol; 2007; 25(1):67-74. PubMed ID: 17417993
[TBL] [Abstract][Full Text] [Related]
8. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor necrosis factor α inhibitors on spinal radiographic progression in patients with ankylosing spondylitis.
Jeong H; Eun YH; Kim IY; Park EJ; Kim H; Lee J; Jeon CH; Koh EM; Cha HS
Int J Rheum Dis; 2018 May; 21(5):1098-1105. PubMed ID: 29611287
[TBL] [Abstract][Full Text] [Related]
10. The application of MR imaging in the detection of hip involvement in patients with ankylosing spondylitis.
Huang ZG; Zhang XZ; Hong W; Wang GC; Zhou HQ; Lu X; Wang W
Eur J Radiol; 2013 Sep; 82(9):1487-93. PubMed ID: 23680154
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels.
Konsta M; Sakellariou GT; Rusman T; Sfikakis PP; Iliopoulos A; van der Horst-Bruinsma IE
Joint Bone Spine; 2021 May; 88(3):105111. PubMed ID: 33278588
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis.
Başkan BM; Sivas F; Inal EE; Duran S; Elverici E; Ozoran K; Bodur H
Clin Rheumatol; 2010 Jan; 29(1):65-70. PubMed ID: 19813046
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature.
Rocha FAC; Pinto ACMD; Lopes JR; Deodhar A
Clin Rheumatol; 2021 May; 40(5):1881-1887. PubMed ID: 33230684
[TBL] [Abstract][Full Text] [Related]
14. Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort.
Sepriano A; Ramiro S; Wichuk S; Chiowchanwisawakit P; Paschke J; van der Heijde D; Landewé R; Maksymowych WP
Arthritis Rheumatol; 2021 Jul; 73(7):1211-1219. PubMed ID: 33538097
[TBL] [Abstract][Full Text] [Related]
15. Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO.
Llop M; Moreno M; Navarro-Compán V; Juanola X; de Miguel E; Almodóvar R; Quintana EC; Sanz JS; Beltrán E; Montesinos MDR; Calvet J; Berenguer-Llergo A; Gratacós J;
Arthritis Res Ther; 2022 Jan; 24(1):30. PubMed ID: 35063018
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Inflammation and Radiographic Progression in Patients With Ankylosing Spondylitis Attaining a BASDAI of Less Than 4 During Tumor Necrosis Factor Inhibitor Treatment.
Koo BS; Oh JS; Park SY; Shin JH; Nam B; Lee S; Joo KB; Kim TH
J Rheumatol; 2022 Dec; 49(12):1328-1334. PubMed ID: 35840153
[TBL] [Abstract][Full Text] [Related]
17. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
18. Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry.
Popova V; Kissling S; Micheroli R; Bräm R; de Hooge M; Baraliakos X; Nissen MJ; Möller B; Exer P; Andor M; Distler O; Scherer A; Ospelt C; Ciurea A
Arthritis Res Ther; 2023 Mar; 25(1):40. PubMed ID: 36915202
[TBL] [Abstract][Full Text] [Related]
19. Determinants of hyperkyphosis in patients with ankylosing spondylitis.
Vosse D; van der Heijde D; Landewé R; Geusens P; Mielants H; Dougados M; van der Linden S
Ann Rheum Dis; 2006 Jun; 65(6):770-4. PubMed ID: 16219704
[TBL] [Abstract][Full Text] [Related]
20. Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
Sari I; Lee S; Tomlinson G; Johnson SR; Inman RD; Haroon N
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):275-281. PubMed ID: 31675169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
